Additional Relevant Details Abbott Vascular filed for approval to the US FDA in Q2 of 2015 for its Absorb GT1 Bioresorbable Vascular Scaffold (BVS).  The FDA will meet, review and vote on Absorb on March 15, 2016.  Absorb functions as a permanent metal stent to open blocked arteries but is made of naturally dissolvable material that leaves behind a restored vessel.  Absorb is currently available in many countries worldwide, but is an investigational drug in the US.  Abbott also filed for regulatory approval for Absorb in China in 2015.